[144] Cencora, Inc. SEC Filing

Rhea-AI Filing Summary

Cencora, Inc. insider sale notice under Rule 144: The filing shows a proposed sale of 4,968 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $1,458,257.04 and an approximate sale date of 08/18/2025. The shares were acquired partly through restricted stock vesting on 09/30/2023 (1,743 shares) as compensation and partly via option exercise on 08/18/2025 (3,225 shares) related to an option granted 11/13/2019 and paid in cash. The filer also disclosed three prior monthly sales of similar sizes in May, June and July 2025 totaling 14,906 shares with gross proceeds of approximately $4.38 million. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full Rule 144 disclosure provided including broker, share counts, acquisition dates and nature of acquisition
• Prior monthly sales disclosed, showing transparency about recent insider dispositions
• Part of the shares originate from restricted stock vesting, indicating compensation-related transfers rather than opportunistic market timing

Negative

• Insider selling is ongoing with three similar monthly sales and a further proposed sale, which could be interpreted negatively by some market participants
• Large aggregate proceeds in recent months (approximately $4.38 million across May–July 2025) reduce insider ownership over time

Insights

Securities Analyst

TL;DR: Routine insider sales disclosed; transaction sizes are modest relative to total shares outstanding and part originate from vesting/options.

The filing documents a scheduled Rule 144 sale of 4,968 common shares via a broker on the NYSE with an aggregate market value of $1.46 million. Acquisition details show 1,743 shares from restricted stock vesting and 3,225 shares from option exercise paid in cash. The seller reported three prior monthly sales in May, June and July 2025 of roughly 4,968 shares each, yielding about $4.38 million in gross proceeds combined. For investors, these disclosures confirm compliance with Rule 144 transfer requirements and establish a pattern of periodic dispositions rather than a single large liquidation.

Corporate Governance Expert

TL;DR: Disclosure is complete and follows Rule 144 format; repeated monthly sales may reflect a prearranged or systematic selling approach.

The form lists the broker, share counts, acquisition dates and nature of acquisition (restricted stock vesting and option exercise). The filer signs the standard attestation about lack of undisclosed material information. The presence of three consistent monthly sales immediately prior to the proposed sale suggests a sustained disposition program, though the filing does not state a 10b5-1 plan adoption date. The document supplies the necessary facts for market participants to assess insider liquidity but does not itself indicate any undisclosed governance issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4968	1458257.04	193877881	08/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2023	Restricted Stock Vesting	Issuer			1743	09/30/2023	Compensation
Common	08/18/2025	Option Granted - 11/13/2019	Issuer			3225	08/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	05/19/2025	4969	1448115.67
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	06/18/2025	4969	1467345.70
Robert P. Mauch 1 West First Avenue Conshohocken PA 19428-1800	Common	07/18/2025	4968	1461138.48

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Cencora (COR) disclose?

The form discloses a proposed sale of 4,968 common shares on 08/18/2025 via Fidelity with an aggregate market value of $1,458,257.04; acquisition sources were restricted stock vesting and option exercise.

How many shares has the filer sold recently in Cencora (COR)?

The filer reported three prior sales: 4,969 shares on 05/19/2025, 4,969 shares on 06/18/2025, and 4,968 shares on 07/18/2025, totaling 14,906 shares.

What were the gross proceeds from the recent sales?

Gross proceeds reported were approximately $1,448,115.67 for May, $1,467,345.70 for June, and $1,461,138.48 for July 2025, totaling about $4.38 million.

Were the sold shares acquired as compensation or purchased?

Yes. 1,743 shares were acquired via restricted stock vesting on 09/30/2023 as compensation; 3,225 shares are reported from an option exercise dated 08/18/2025 (option granted 11/13/2019) paid in cash.

Does the filing state whether a Rule 10b5-1 trading plan was used?

The filing does not indicate a plan adoption date or explicitly state reliance on a Rule 10b5-1 plan.